The Canopy/Acreage Deal Puts Canadian Cannabis Back on the Map

Canopy Growth Corp.’s (TSX:WEED)(NYSE:CGC) deal to buy Acreage Holdings just sent a signal to U.S. investors that Canadian Cannabis companies are the real deal. Here’s why.

| More on:
edit Business accounting concept, Business man using calculator with computer laptop, budget and loan paper in office.

Image source: Getty Images

“We’re very bullish on the globe, on the U.S. — not so much on Canada,” stated CB1 Capital partner Loren DeFalco recently.

DeFalco wasn’t talking about the Canadian cannabis companies themselves but rather the cannabis marketplace in this country where companies like Canopy Growth (TSX:WEED)(NYSE:CGC) face severe advertising restrictions and regulatory choke holds that keep retail distribution from really thriving.

Sure, Canadian cannabis leaves a lot to be desired right now, but five years from now companies like Canopy will make sure it’s a different story.

Canada’s smaller market

And it’s hard to ignore the fact that California’s pot market is bigger than all of Canada, a reality that’s haunted Canadian companies for more than a century. The U.S. market, even in its current half-in, half-out state of legality, is still far more attractive in terms of population.  

Currently, there are 10 states where recreational pot is legal including California. The population of those states adds up to almost 80 million people, or more than double Canada’s population. Of course, the U.S. market is more attractive.

However, that doesn’t mean investors should avoid cannabis companies based in Canada simply because their home market is a little dysfunctional at the moment.

Canada’s cannabis marketplace will grow over time to be an attractive middle-market opportunity. The black market here in Canada accounts for 81% of the demand for cannabis. By 2020, it’s expected to drop to 59% by the end of 2020.

It won’t be nearly as big as the U.S. and several countries in Europe, but it will hold its own.

Plenty of expertise

What Canada might lack in market size, it more than makes up for it in terms of industry experience. There are a lot of smart people working in facilities from coast-to-coast to produce some of the best pot in the world. You can’t put a dollar value on this intangible.

The global market might be a big one, but the head start Canada’s gained from being the second country in the world to legalize cannabis will remain an advantage as long as Canadian companies continue to take risks, innovate, and reach well beyond its borders.

The Acreage deal

Canopy’s recent agreement to obtain the right to buy Acreage Holdings for US$300 million down in cash and the issuance of 0.5818 Canopy Growth shares for every Acreage share held once cannabis is legalized on the federal level in the U.S. is a game changer.  

The tentative acquisition is valued at US$3.4 million. It gives Canopy future access to a business with cannabis licenses in 20 states without running afoul of the New York Stock Exchange or federal lawmakers.

While there is a risk that the feds won’t legalize pot within the seven years of the agreement between the two companies, I believe it’s a risk worth taking. Canopy already has a lot on its plate both here in Canada and overseas, and the delay will give it more time to understand the U.S. market while getting edibles and infused drinks ready for Canadian consumption.

It made a smart move partnering with Constellation Brands to make infused drinks — not to mention bringing an owner with a boatload of global distribution experience onboard — and now it’s looking to dip its toe in the U.S. market.

I, for one, would be shocked if, after the November 2020 U.S. election, cannabis wasn’t legalized within 6-12 months.

In my opinion, Canopy’s deal for Acreage just put Canadian cannabis back on the map.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned.  

More on Investing

analyze data
Tech Stocks

Nuvei Stock Is on Fire This Year: Is it a Good Buy Today?

For investors looking for a prominent Canadian growth story, Nuvei stock has become a clear winner, but can the rally…

Read more »

stock analysis

Is BCE Stock a Buy?

BCE (TSX:BCE) stock looks incredibly attractive, as shares pick up again, while the yield remains bountiful.

Read more »

analyze data
Dividend Stocks

The Best Dividend Stocks in Canada Right Now

Earn worry-free income from these best Canadian dividend stocks.

Read more »

Value for money
Dividend Stocks

3 Top Canadian Value Stocks in December 2023

Not all undervalued stocks are worth buying. You should look into the fundamental strengths of the stocks and reconcile value…

Read more »

calculate and analyze stock

2 TSX Stocks to Dominate the Market in 2024

Two stocks with market-beating returns with one month to go this year are the frontrunners to dominate the market in…

Read more »

Young woman sat at laptop by a window

SPY Stock Is Just the Tip of the Iceberg for Canadians Investing in the U.S.

These two BMO ETFs are great alternatives to just buying SPY.

Read more »

TFSA and coins
Stocks for Beginners

How a BIG New TFSA Change Could Affect You in 2024

Canadians are in for a BIG surprise for the TFSA in 2024. Here's how TFSA changes could help you keep…

Read more »

Growing plant shoots on coins
Dividend Stocks

2 Under-the-Radar Dividend Payers With Solid Growth Prospects in 2024

These under the radar monthly dividend payers could provide good growth prospects in 2024 and beyond.

Read more »